Actuate Therapeutics Inc
ACTU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $67 | $129 | $129 |
| - Cash | $9 | $3 | $20 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $58 | $126 | $109 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$25 | -$24 | -$20 |
| % Margin | – | – | – |
| Net Income | -$27 | -$25 | -$20 |
| % Margin | – | – | – |
| EPS Diluted | -3.26 | -1.65 | -1.34 |
| % Growth | -97.6% | -23.1% | – |
| Operating Cash Flow | -$22 | -$22 | -$18 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$22 | -$22 | -$18 |